SJ:AIP Adcock Ingram Holdings Limited

Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products primarily in Zimbabwe, Kenya, and Southern Africa. It offers a portfolio of prescription medicines, generic products, critical care, and over-the-counter products. The company provides pharmaceutical products in a range of therapeutic classes, such as women's health, antiretroviral, allergies, dermatology, cardiovascular, central nervous system, respiratory, ophthalmic, urology, pain, vitamins, minerals supplements, infections, gastroenterology, baby care, pain and inflammation, cough, energy supplements, colds and flu, personal care, food & nutrition supplements, feminine hygiene, and digestive well-being. It also manufactures and supplies hospital and critical care products, including intravenous fluids, renal dialysis systems, products for the storage of blood and blood components, infusion systems, and accessories. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

5,300.00 ZAR
As of 03/08/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  South Africa
Country of incorporation:  South Africa
IPO date:  12/31/2009
Stock exchange:    Johannesburg Stock Exchan
Exchange country:   South Africa
Market cap:   7,377,782,380 ZAR
Current dividend yield:   4.04%
Sedol:      B3BX6X3

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy